Clinical Significance and Mechanistic Role of circLPAR3/miR-634 in Ischemic Stroke

Jinli Chen1, Jing Yang2, Quan Wu1

  • 1Department of Neurology, Tinglin Hospital of Jinshan District, Shanghai, 201505, China.

Insights

Circular RNA LPAR3 (circLPAR3) levels are decreased in patients with ischemic stroke (IS). Upregulating circLPAR3 protects against IS by reducing neuronal apoptosis and inflammation, offering a potential therapeutic target for stroke patients.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neuroscience

Background:

  • Hypertension is a significant risk factor for ischemic stroke (IS), a leading cause of human disability and mortality.
  • Understanding the molecular mechanisms underlying IS is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To investigate the role of circular RNA LPAR3 (circLPAR3) in the pathogenesis of IS.
  • To elucidate the functional effects and molecular mechanisms of circLPAR3 in IS.

Main Methods:

  • Quantification of mRNA abundance using RT-qPCR in patients and cell/animal models.
  • In vivo studies using mice subjected to middle cerebral artery occlusion (MACO) and in vitro studies using oxygen-glucose deprivation/reoxygenation (OGD/R) in Neuro-2a cells.
  • Luciferase reporter and RNA immunoprecipitation (RIP) assays to determine molecular interactions.

Main Results:

  • Plasma circLPAR3 levels were significantly reduced in IS patients compared to essential hypertension (EH) patients and served as an independent predictor of poor prognosis.
  • Overexpression of circLPAR3 in vivo ameliorated neurological deficits and infarct volume in MACO-treated mice.
  • circLPAR3 upregulation attenuated OGD/R-induced neuronal apoptosis and pro-inflammatory cytokine release in vitro.
  • circLPAR3 acts as a molecular sponge for miR-634, and KLB is a downstream target mediating circLPAR3's neuroprotective effects.

Conclusions:

  • circLPAR3 plays a protective role in IS by inhibiting neuronal apoptosis and inflammation.
  • The circLPAR3/miR-634/KLB axis represents a potential therapeutic target for managing IS.

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...